Cardiac resynchronization therapy: past, present, and future

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Cardiac resynchronization therapy (CRT) is a proven treatment for advanced heart failure with specific conduction delays.
• Clinical trials confirm CRT's efficacy in improving exercise capacity, functional class, and quality of life.
• Recent evidence highlights CRT's role in reducing overall mortality in heart failure patients.

Purpose of the Study:

• To review the existing evidence supporting current CRT indications.
• To explore unanswered questions regarding patient selection for CRT.
• To discuss potential future expansions of CRT clinical use.

Main Methods:

• Literature review of published clinical trials and studies on CRT.
• Analysis of data demonstrating CRT's impact on clinical parameters and mortality.
• Discussion of emerging research and clinical considerations for CRT.

Main Results:

• CRT is supported by extensive clinical trial data showing benefits in heart failure management.
• Established benefits include improved exercise capacity, functional status, and quality of life.
• CRT has demonstrated a significant reduction in total mortality rates for eligible patients.

Conclusions:

• Current indications for CRT in heart failure are well-established by robust clinical evidence.
• Further research is needed to optimize patient selection criteria for CRT.
• Expanding CRT indications to new patient groups represents a key area for future clinical development.